Results     13-May-22
Announcements
Orchid Pharma reports consolidated net loss of Rs 6.59 crore in the March 2022 quarter
Sales rise 48.99% to Rs 178.13 crore
Net Loss of Orchid Pharma reported to Rs 6.59 crore in the quarter ended March 2022 as against net loss of Rs 24.73 crore during the previous quarter ended March 2021. Sales rose 48.99% to Rs 178.13 crore in the quarter ended March 2022 as against Rs 119.56 crore during the previous quarter ended March 2021.

For the full year,net loss reported to Rs 1.95 crore in the year ended March 2022 as against net loss of Rs 116.53 crore during the previous year ended March 2021. Sales rose 24.33% to Rs 559.56 crore in the year ended March 2022 as against Rs 450.06 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales178.13119.56 49 559.56450.06 24
OPM %12.77-3.18 -8.876.33 -
PBDT20.03-4.40 LP 85.07-7.61 LP
PBT-6.59-24.73 73 -1.95-116.53 98
NP-6.59-24.73 73 -1.95-116.53 98

Previous News
  Sensex up 273 pts; IT shares outperforms
 ( Market Commentary - Mid-Session 06-Jun-24   14:42 )
  Orchid Pharma reports consolidated net profit of Rs 7.59 crore in the December 2022 quarter
 ( Results - Announcements 10-Feb-23   07:38 )
  Orchid Pharma reports consolidated net loss of Rs 24.42 crore in the September 2020 quarter
 ( Results - Announcements 12-Nov-20   08:34 )
  Orchid Chemicals jumps after completing Phase I study of a molecule
 ( Hot Pursuit - 02-Jan-12   15:37 )
  Orchid Chemicals & Pharmaceuticals net profit declines 2.42% in the September 2011 quarter
 ( Results - Announcements 01-Nov-11   14:49 )
  Orchid Pharma to announce Quarterly Result
 ( Corporate News - 30-Oct-23   19:26 )
  Orchid Pharma gains on DCGI nod for new antibiotic drug combination
 ( Hot Pursuit - 06-Jun-24   12:38 )
  Orchid Pharma receives DCGI approval for Enmetazobactam
 ( Corporate News - 06-Jun-24   13:06 )
  Orchid Chemicals & Pharmaceuticals
 ( Analyst Meet / AGM - Conference Call 09-Feb-12   11:19 )
  Orchid Pharma to hold board meeting
 ( Corporate News - 04-Feb-23   11:09 )
  Orchid Pharma receives USFDA approval for Enmetazobactam
 ( Corporate News - 23-Feb-24   17:12 )
Other Stories
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top